These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11779776)

  • 21. Chloroquine and cytokines.
    Wallace DJ
    J Rheumatol; 1997 Oct; 24(10):2051-2. PubMed ID: 9330956
    [No Abstract]   [Full Text] [Related]  

  • 22. [Novel therapeutic possibilities in systemic lupus erythematosus].
    Bazsó A; Poór G; Gergely P; Kiss E
    Orv Hetil; 2010 May; 151(18):735-40. PubMed ID: 20410000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.
    Martin MF; Dowd PM; Ring EF; Cooke ED; Dieppe PA; Kirby JD
    Ann Rheum Dis; 1981 Aug; 40(4):350-4. PubMed ID: 7259326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ischemic necrosis of the femoral head in systemic lupus erythematosus].
    Shimoni Z; Reichman N; Flatau E
    Harefuah; 1987 Jan; 112(1):11-2. PubMed ID: 3609918
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytokines in the pathogenesis of systemic lupus erythematosus.
    Kelley VR; Wüthrich RP
    Semin Nephrol; 1999 Jan; 19(1):57-66. PubMed ID: 9952281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raynaud's phenomenon as leading sign in lupus erythrmatosus--report of three cases and classification of cryopathies.
    Kenamore BD; Levin WC; Ritzmann SE
    Tex Rep Biol Med; 1968; 26(2):189-97. PubMed ID: 5675206
    [No Abstract]   [Full Text] [Related]  

  • 27. Prostaglandins in therapy of cardiovascular disease.
    Szczeklik A; Gryglewski RJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():345-54. PubMed ID: 3159222
    [No Abstract]   [Full Text] [Related]  

  • 28. The fine page.
    Fine RM
    Int J Dermatol; 1978 Apr; 17(3):220. PubMed ID: 649249
    [No Abstract]   [Full Text] [Related]  

  • 29. The potential role of immunoregulatory disturbance in the pathogenesis of systemic lupus erythematosus.
    Bell DA
    J Rheumatol; 1981; 8(2):340-4. PubMed ID: 6971937
    [No Abstract]   [Full Text] [Related]  

  • 30. [Lupus erythematosus--a model of an autoimmune disease].
    Sönnichsen N
    Dermatol Monatsschr; 1985; 171(8):481-92. PubMed ID: 3899754
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vital capillary microscopic examination and transcutaneous pO2-measurements by intravenous prostaglandin E1 infusion].
    Heidrich H; Lammersen T
    Dtsch Med Wochenschr; 1985 Aug; 110(34):1283-5. PubMed ID: 4040847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study and therapy of pulmonary hypertension in systemic lupus erythematosus].
    Inokuma S
    Nihon Naika Gakkai Zasshi; 1990 Oct; 79(10):1399-403. PubMed ID: 2269815
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms of lupus: the role of estrogens.
    Yung RL
    Clin Exp Rheumatol; 1999; 17(3):271-5. PubMed ID: 10410256
    [No Abstract]   [Full Text] [Related]  

  • 34. Raynaud's phenomenon in systemic lupus erythematosus.
    Lavras Costallat LT; Valente Coimbra AM
    Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Systemic lupus erythematosus: disease or syndrome?].
    Font J; Cardellach F
    Med Clin (Barc); 1985 Apr; 84(16):657-9. PubMed ID: 3875769
    [No Abstract]   [Full Text] [Related]  

  • 36. Identity loss due to chronic fingertip ischemia.
    Crispin JC; Fallena M; Kraus A
    J Rheumatol; 2004 Jun; 31(6):1222-4. PubMed ID: 15170940
    [No Abstract]   [Full Text] [Related]  

  • 37. A study of migraine in systemic lupus erythematosus.
    Isenberg DA; Meyrick-Thomas D; Snaith ML; McKeran RO; Royston JP
    Ann Rheum Dis; 1982 Feb; 41(1):30-2. PubMed ID: 7065726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fc gamma receptor-bearing T lymphocytes in systemic lupus erythematosus in relation to disease activity and treatment].
    Rautenstrauch H; Saal JG; Frank F
    Immun Infekt; 1982 Nov; 10(6):240-3. PubMed ID: 6223879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rapidly developing scleroderma with associated symptoms of dermatomyositis and lupus erythematosus].
    Grupper C; Durepaire RM; Choffel M
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):318-9. PubMed ID: 5510715
    [No Abstract]   [Full Text] [Related]  

  • 40. [Etiologic mechanism of systemic lupus erythematosus].
    Miyasaka N
    Nihon Naika Gakkai Zasshi; 1990 Oct; 79(10):1343-7. PubMed ID: 2269806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.